Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigating the effect of melatonin in patients with chronic renal failure
IRCT20241008063295N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in chronic kidney disease (CKD), sponsored by Yasouj University of Medical Sciences. Started Oct 2024; status: completed.
02
Drugs
melatonin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20241008063295N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241008063295N1.